News Protalix BioTherapeutics, Inc.

Equities

PLX

US74365A3095

Market Closed - Nyse Other stock markets 04:00:00 2024-05-17 pm EDT			5-day change	1st Jan Change
1.14 ^USD	-2.56%		+3.64%	-35.96%

May. 10	Transcript : Protalix BioTherapeutics, Inc., Q1 2024 Earnings Call, May 10, 2024
May. 10	Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Protalix BioTherapeutics : PLX Corporate Presentation (May 2024)	10:12pm	PU
Protalix BioTherapeutics Reports First Quarter 2024 Financial and Business Results	May. 13	AQ
Transcript : Protalix BioTherapeutics, Inc., Q1 2024 Earnings Call, May 10, 2024	May. 10
Protalix BioTherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 10	CI
Earnings Flash (PLX) PROTALIX BIOTHERAPEUTICS Reports Q1 Revenue $3.7M, vs. Street Est of $9.2M	May. 10	MT
Protalix: Q1 Earnings Snapshot	May. 10	AQ
Protalix BioTherapeutics to Announce First Quarter 2024 Financial and Business Results on May 10, 2024	May. 06	AQ
Protalix BioTherapeutics Reports Fiscal Year 2023 Financial and Business Results	Mar. 15	AQ
Transcript : Protalix BioTherapeutics, Inc., 2023 Earnings Call, Mar 14, 2024	Mar. 14
Protalix BioTherapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 14	CI
Protalix BioTherapeutics to Announce Fiscal Year 2023 Financial and Business Results on March 14, 2024	Mar. 08	AQ
Protalix BioTherapeutics to Participate in the 2024 BIO CEO and Investor Conference	Feb. 26	AQ
Protalix BioTherapeutics Reports Third Quarter 2023 Financial and Business Results	Nov. 07	AQ
Transcript : Protalix BioTherapeutics, Inc., Q3 2023 Earnings Call, Nov 06, 2023	Nov. 06
Protalix BioTherapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 06	CI
Protalix: Q3 Earnings Snapshot	Nov. 06	AQ
Earnings Flash (PBDA) PROTALIX BIOTHERAPEUTICS Reports Q3 Revenue $10.3M	Nov. 06	MT
Protalix BioTherapeutics to Announce Third Quarter 2023 Financial and Business Results on November 6, 2023	23-10-31	AQ
HC Wainwright Adjusts Protalix BioTherapeutics' Price Target to $10 From $7, Keeps Buy Rating	23-10-31	MT
Protalix BioTherapeutics : PLX Corporate Presentation (October 2023)	23-10-23	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Protalix BioTherapeutics, Inc.

Equities

PLX

US74365A3095

Summary

Filters